Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03904654 · ClinicalTrials.gov registry record · NA

Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT03904654 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03904654, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease.

Interventions

  • BEHAVIORAL Mindfulness-based cognitive therapy (MBCT)

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-08-26
Est. Completion 2020-04-06
Phase NA

What the Registry Record Tells You About NCT03904654

The ClinicalTrials.gov registry entry for NCT03904654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mindfulness-based cognitive therapy (MBCT) is the first listed.

NCT03904654 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03904654 about?

NCT03904654 is a clinical study titled "Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease". This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease.

What is the current status of trial NCT03904654?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-08-26. Estimated completion is 2020-04-06.

What interventions are being tested in trial NCT03904654?

The interventions under investigation include: Mindfulness-based cognitive therapy (MBCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03904654?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.